Intelligent Statistical Monitoring Study Signals

How can we combat the sense of urgency our professional lives bring?

Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences highlights how awareness and clinical innovation have transformed research in the HIV space.

Decentralized clinical trials have the potential to expand the number of people who can benefit from clinical trials while accelerating therapies to more patients in need.

Insightful sound bytes from KOLs attending SCOPE EUROPE 2023.

Study teams often face challenges in maintaining detailed and accurate documentation of risk signals.

Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.